Eye Witness 37 - Mar 2019

Inside issue #37:

• The Future Builds on the Past  
• Hospitalist Program is New Interface in Medicine
• Outcome Measures for Ophthalmology
• An Exciting New Era for Patients with IRDs  
• Dr. Wiggs Elected to NAM

Download the full issue or read highlights below.

The Future Builds on the Past

Ever wonder how breakthroughs in medicine occur? Chief and Chair, Joan W. Miller, MD, delves into the process behind pivotal developments in medicine.  

Find out how we can accelerate breakthroughs

Hospitalist Program is New Interface in Medicine

Jo-Ann Haney-Tilton, MD	Jane Schweitzer, MD	Aisha Traish, MD

The newly launched Ophthalmology Hospitalist Program at Mass. Eye and Ear is a one-of-a-kind emergency department and inpatient consultation service for patients admitted to Mass General Hospital and Brigham and Women's Hospital (Main Campus and Faulkner).  

Learn how affiliates and trainees benefit 

Outcome Measures for Ophthalmology

Mass. Eye and Ear continues to lead the way in developing outcome measures for ophthalmology. This includes: 

• Publishing an annual Quality and Outcomes Report
• Developing patient-reported outcome measures for cataract procedures 
• Participating in the IRIS Registry—the nation's first comprehensive eye disease and condition registry

Why is collecting data important?

An Exciting New Era for Patients with IRDs

Since the 1970s, inherited retinal degenerations (IRDs) have been a key area of focus in the Harvard Department of Ophthalmology. Now, the Ocular Genomics Institute is leading the way in clinical research and new treatments for patients with IRDs. 

Find out how research of IRDs has evolved

Dr. Janey L. Wiggs Elected to NAM

Internationally renowned medical geneticist and glaucoma specialist Janey L. Wiggs, MD, PhD, has been elected to the National Academy of Medicine (NAM).  

Learn about Dr. Wiggs' achievements that led to this prestigious recognition 

Read More....